Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Gobbini E, Toffart AC, Pérol M, Assié JB, Duruisseaux M, Coupez D, Dubos C, Westeel V, Delaunay M, Guisier F, Veillon R, Gounant V, Giroux Leprieur E, Vanel FR, Chaabane N, Dansin E, Babey H, Decroisette C, Barlesi F, Daniel C, Fournel P, Mezquita L, Oulkhouir Y, Canellas A, Duchemann B, Molinier O, Alcazer V, Moro-Sibilot D, Levra MG. Gobbini E, et al. Among authors: perol m. Clin Lung Cancer. 2020 Sep;21(5):e497-e510. doi: 10.1016/j.cllc.2020.04.013. Epub 2020 May 8. Clin Lung Cancer. 2020. PMID: 32605892
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).
Trillet-Lenoir V, Mornex F, Chauvin F, Fournel P, Voloch A, Perol M, Laennec E, Piperno D, Boyer J, Ardiet JM, et al. Trillet-Lenoir V, et al. Among authors: perol m. Lung Cancer. 1993 Oct;10(1-2):35-45. doi: 10.1016/0169-5002(93)90307-j. Lung Cancer. 1993. PMID: 8069602 Clinical Trial.
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
Pérol M, Guérin JC, Thomas P, Poirier R, Carles P, Robinet G, Kleisbauer JP, Paillotin D, Vergnenègre A, Balmes P, Touron D, Grivaux M, Pham E. Pérol M, et al. Lung Cancer. 1996 Feb;14(1):119-34. doi: 10.1016/0169-5002(95)00517-x. Lung Cancer. 1996. PMID: 8696715 Clinical Trial.
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results.
Sunyach MP, Falchero L, Pommier P, Perol M, Arpin D, Vincent M, Boutry D, Rebatu P, Ginestet C, Martel-Lafay I, Perol D, Carrie C. Sunyach MP, et al. Among authors: perol d, perol m. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):459-63. doi: 10.1016/s0360-3016(00)00618-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10974462
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
Robinet G, Thomas P, Breton JL, Léna H, Gouva S, Dabouis G, Bennouna J, Souquet PJ, Balmes P, Thiberville L, Fournel P, Quoix E, Riou R, Rebattu P, Pérol M, Paillotin D, Mornex F. Robinet G, et al. Among authors: perol m. Ann Oncol. 2001 Jan;12(1):59-67. doi: 10.1023/a:1008338312647. Ann Oncol. 2001. PMID: 11249050 Free article. Clinical Trial.
278 results